Federal appeals court rules on mail-order access to abortion pill
A federal appeals court has issued a ruling regarding the distribution of mifepristone. This decision may lead to additional legal proceedings. (sources: foxnews, washingtonpost, bbc, abcnews, thehill)
The federal appeals court's ruling blocks the mail distribution of mifepristone, a drug commonly used in medication abortions, and ends pandemic-era regulations. The decision may be appealed to the Supreme Court.
- The appeals court's ruling applies nationwide and restricts access to mifepristone.
- The decision ends rules that allowed for mail-order distribution of the drug during the pandemic.
- Mifepristone is the most common method for medication abortions in the US.
Why it matters
The ruling could impact access to abortion services across the country.
↓ Why this is on ModernAction
3 bills on this issue are moving right now — and the most active one is Protecting Life from Chemical Abortions Act.
HR1525 · 119th Congress
Protecting Life from Chemical Abortions Act
Where do you stand on this bill?
Takes about 60 seconds
About this bill
What HR1525 actually does
This story is about Federal appeals court rules on mail-order access to abortion pill. This bill would nullify FDA’s January 2023 mifepristone REMS changes tied to mail/retail dispensing.
If passed, it would:
- Nullify FDA’s January 2023 mifepristone REMS changes tied to mail/retail dispensing • Add additional constraints on HHS/FDA actions related to abortion-drug safeguards (per CRS summary.
2 other bills moving on this issue
Take action on any of them individually.
This story is about a US court order that limits mail delivery of the abortion pill and blocks nationwide mail distribution. This bill would amend federal laws tied to mailing restrictions to reduce legal barriers on shipping abortion-related items by mail.
If passed, it would
- Amend federal law to limit use of Comstock-era mailing bans • Reduce legal uncertainty around mailing abortion-related items.
This story is about Federal appeals court rules on mail-order access to abortion pill. This bill would direct HHS to replace the current mifepristone REMS with a prior version.
If passed, it would
- Direct HHS to replace the current mifepristone REMS with a prior version (per bill text description on Congress.gov • Potentially limit pharmacy/mail pathways that depend on the current REMS structure.
Top coverage · 10 sources